跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEFAZOLIN FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CEFAZOLIN FOR INJECTION
Authorized
STANDARD
CEFAZOLIN FOR INJECTION
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9b242711c0b63064
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
9b242711c0b63064
Drug Approval Canada Name
CEFAZOLIN FOR INJECTION
Product Name
CEFAZOLIN FOR INJECTION
Status
Cancelled Post Market
Status Date
2024-08-28
Original Market Date
2016-07-27
Din
02452162
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.06.04
Atc Original
J01DB04 CEFAZOLIN
Atc Name
j 01 db 04
Aig Number
0109442006
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
CEFAZOLIN (CEFAZOLIN SODIUM)
10 G / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9b242711c0b63064
Type
Standard
Back to Health Canada Approvals